U.S. Entertainment Stock News

Energy Recovery (ERII) closed out FY 2025 with Q4 revenue of US$66.9 million and basic EPS of US$0.51, alongside net income of US$26.9 million, putting a clear spotlight on the profitability picture heading into the new year. The company has seen quarterly revenue move from US$38.6 million in Q3 2024 to US$67.1 million in Q4 2024 and then to US$66.9 million in Q4 2025, while basic EPS over the same Q4 periods went from US$0.41 to US$0.51, setting the stage for investors to focus on what is...

In February 2026, Global Business Travel Group, Inc. issued full-year 2026 guidance calling for revenue growth of 19% to 21% to US$3.24–US$3.30 billion and expanded its equity buyback authorization to US$600 million after completing a US$100 million repurchase of 13,090,156 shares since November 2024. The combination of ambitious revenue guidance and a much larger share repurchase program signals management’s conviction in the company’s trajectory and capital allocation priorities at a time...

Sun Communities (SUI) has drawn fresh attention after recent share gains, with the stock up around 5% over the past week and roughly 7% over the past month. This performance has prompted closer scrutiny of its fundamentals. See our latest analysis for Sun Communities. That recent strength continues a broader upswing, with an 11.18% year to date share price return and a 12.93% five year total shareholder return, suggesting improving sentiment toward Sun Communities after a more modest 8.73%...

If you are wondering whether Procore Technologies at around US$55.81 is priced attractively today, it helps to step back and look at how its current share price lines up with a few core valuation checks. The stock has moved 7.3% over the last 7 days, while the 30 day return sits at an 11.6% decline and the year to date return is a 20.3% decline, with a 26.5% decline over 1 year and a 16.8% decline over 3 years, which may have changed how investors view both its potential and its...

If you are wondering whether Royalty Pharma's current share price reflects its true worth, you are not alone and that is exactly what this article will help you unpack. The stock recently closed at US$45.36, with returns of 0.6% over 7 days, 11.3% over 30 days, 16.7% year to date, 39.2% over 1 year, 39.3% over 3 years and 20.4% over 5 years, which naturally raises questions about how much of this performance is already priced in. Recent news around Royalty Pharma has largely focused on its...

If you are wondering whether Packaging Corporation of America is still reasonably priced after its recent run, this article will walk through what the current share price could imply about value. The stock last closed at US$231.83, with returns of 3.7% over 30 days and 9.8% year to date, while the 1 year and 3 year returns stand at 12.8% and 79.0% respectively and the 5 year return is 100.5%. Recent coverage around the company has kept attention on how the packaging sector is positioned...

If you are wondering whether Bank of America at around US$52.30 is still a sensible entry point or starting to look expensive, you are not alone. The stock has had a mixed run, with a 0.2% move over the past month, a 21.3% return over the last year, and a 6.5% decline year to date. These moves can change how investors think about both upside and risk. Recent coverage has focused on large US banks like Bank of America as investors reassess interest rate expectations and the health of the...

Wave Life Sciences (WVE) has just closed out FY 2025 with fourth quarter revenue of US$17.2 million, a basic EPS loss of US$0.30 and net income loss of US$53.2 million, following a prior year fourth quarter that carried revenue of US$83.7 million and basic EPS of US$0.18. Over recent quarters the company has seen revenue move from US$9.2 million in Q1 2025 to US$8.7 million in Q2 and US$7.6 million in Q3, while quarterly basic EPS held in a relatively tight loss range between US$0.29 and...

Crown Castle (CCI) has moved to the forefront for income focused investors after affirming a quarterly cash dividend of $1.0625 per share, payable on March 31, 2026, to shareholders of record on March 13. See our latest analysis for Crown Castle. The latest dividend affirmation comes as Crown Castle’s share price sits at US$86.40, with a recent 90 day share price return showing a 5.35% decline and a five year total shareholder return showing a 26.97% decline. This points to fading longer term...

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...

How Middleby’s FY 2025 Earnings Set the Stage for the Next Chapter Middleby (MIDD) closed FY 2025 with fourth quarter revenue of US$866.4 million and EPS of US$1.73, while trailing 12 month EPS came in at US$7.11 on revenue of US$6.4 billion and earnings growth of 71.3% year over year. Over recent periods, the company has seen quarterly revenue move between US$942.8 million and US$1.0 billion in late 2024 and a range of US$866.4 million to US$982.1 million through 2025, with quarterly EPS...

Are you wondering whether Cabot shares offer good value at today's price, or whether you might be overpaying for the story the market is telling right now? The stock last closed at US$75.81, with returns of 1.2% over the past week, 5.9% over the past month, 13.1% year to date, an 8.6% decline over the past year, a 1.6% decline over three years, and 72.7% over five years. This pattern hints that the market's view of risk and opportunity around Cabot has shifted over time. Recent news coverage...

In late February 2026, JPMorgan Chase & Co. warned that current market conditions and some banks’ risky lending resemble the pre-2008 financial crisis, while also outlining heavy investment in AI, technology, and branch expansion alongside a very large new US$80.00 billion universal debt shelf registration and multiple bond offerings. Jamie Dimon’s twin message of caution about credit and AI-driven job disruption, paired with aggressive spending and issuance, highlights how JPMorgan is...

Sirius XM Holdings' subsidiary has launched an upsized $1.25b senior notes offering. The company is also conducting a cash tender offer for its outstanding 2026 notes. The transactions are aimed at adjusting the company's existing debt profile. Sirius XM Holdings, listed on NasdaqGS:SIRI, is reshaping part of its balance sheet with this new debt issuance and tender offer. The stock trades at $21.52, with returns of 2.3% over the past week and 6.6% over the past month, while the 1 year and...

York Space Systems (YSS) has been drawing fresh attention after reporting annual revenue of $357.46 million alongside a net income loss of $90.647 million. This combination naturally raises questions about how the stock’s current pricing reflects its risk and potential. See our latest analysis for York Space Systems. With the share price at $26.17, York Space Systems has recorded a 1-day share price return of a 1.10% decline, a 7-day share price return of an 8.40% decline, and a year-to-date...

Rollins (ROL) is back in focus after Q4 2025 organic revenue growth of 5.7% came in below expectations due to poor weather, while management outlined 2026 guidance of 9% to 11% revenue growth and higher EBITDA margins. See our latest analysis for Rollins. Rollins' share price has softened in recent weeks, with a 30 day share price return of 5.9% and a 90 day share price return of 2.8%. This comes even as its 1 year total shareholder return of 17.7% and 5 year total shareholder return of 99.6%...

Enovix (ENVX) closed FY 2025 with Q4 revenue of US$11.3 million, a basic EPS loss of US$0.16 and a net income loss of US$35.0 million. Over recent quarters the company has seen revenue move from US$9.7 million in Q4 2024 to US$11.3 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.16. This sets the stage for investors to focus on how quickly margins might tighten or widen from here. See our full analysis for Enovix. With the headline numbers on the...

Northern Oil and Gas (NOG) FY 2025 earnings snapshot Northern Oil and Gas (NOG) has wrapped up FY 2025 with fourth quarter revenue of US$419.9 million and a basic EPS loss of US$0.73, while on a trailing twelve month basis revenue sits at about US$2.0 billion and EPS is US$0.40. Over recent periods, revenue has moved from US$506.6 million and EPS of US$0.72 in Q4 2024 to the latest Q4 2025 figures. Trailing EPS has stepped down from US$5.21 a year earlier to US$0.40 now. With net profit...

Installed Building Products FY 2025 Earnings Snapshot Installed Building Products (IBP) has wrapped up FY 2025 with fourth quarter revenue of US$747.5 million and basic EPS of US$2.85, alongside net income excluding extra items of US$76.6 million as the market weighs the results against a share price of US$322.01. Over recent quarters, the company has seen quarterly revenue move between US$684.8 million and US$778.2 million, while basic EPS has ranged from US$1.65 to US$2.85 and trailing 12...

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...

USA TODAY (TDAY) has just posted its FY 2025 numbers with Q4 revenue of US$585.0 million, basic EPS of a US$0.21 loss, and a net income loss of US$30.1 million. The trailing twelve month line shows basic EPS of US$0.01 on revenue of about US$2.3 billion and net income of US$1.7 million. Over recent periods, revenue has moved between US$560.8 million and US$621.3 million a quarter, while basic EPS has ranged from a loss of US$0.27 to a gain of US$0.54. This puts the latest print in the middle...

Xencor (XNCR) has just posted its FY 2025 numbers, with Q4 revenue of US$28.2 million, a basic EPS loss of US$0.09, and net income loss of US$6.7 million, while on a trailing twelve month basis revenue came in at US$125.6 million and EPS at a loss of US$1.24 alongside a net income loss of US$91.9 million. Over recent quarters the company has seen revenue range from US$17.8 million to US$70.0 million per quarter, while basic EPS has moved between a loss of US$0.08 and a loss of US$0.73,...

Agilon health (AGL) just posted its FY 2025 numbers with Q4 revenue at US$1.6 billion and a basic EPS loss of US$0.46, capping a trailing twelve month revenue base of US$5.9 billion and a full year EPS loss of US$0.98. The company has seen quarterly revenue move between US$1.4 billion and US$1.6 billion over the last six quarters, while basic EPS has ranged from a small quarterly loss of US$0.00 in early 2025 to a loss of US$0.46 in the latest period, keeping profitability firmly in the red...

Why BorgWarner (BWA) is on investors’ radar today BorgWarner (BWA) has drawn fresh attention after a recent move in its share price, with the stock showing a strong rebound over the past 3 months and a solid gain over the past year. See our latest analysis for BorgWarner. The recent pullback, including a 2.59% 1 day share price decline to US$57.91, comes after a sharp rebound, with a 30 day share price return of 19.57% and a 1 year total shareholder return of 98.53%. This suggests that...